AzTrials
AzTrials

Electronic Cigarette UseNCT06142877

Effects of Social Media Use on Young Adults' E-Cigarette Use

A study testing Social Media Use Reduction in people with Electronic Cigarette Use, run by University of Oklahoma at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are: Does reducing social media use change young adults' e-cigarette use? Does reducing social media use change things such as young adults' mental… Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Electronic Cigarette Use
What is being tested?
Social Media Use Reduction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
4 Dec 2023to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-25
  • Daily social media use
  • Ownership of a smartphone
  • Vaping (i.e., use of a nicotine e-cigarette) on 1-19 days of the past 30 days
  • Residing in the United States

Who cannot join

  • -Lack of capacity to provide informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104

    Erin A Vogel, PhD, 405-271-8001 ext. 50493, erin-vogel@ouhsc.edu

    Recruiting

Other trials in United States

About this study

Official title: Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach

The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are:

  • Does reducing social media use change young adults' e-cigarette use?
  • Does reducing social media use change things such as young adults' mental health and what they see on social media?

Participants will complete surveys and submit screenshots showing how much time they spend on social media.

Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.

Read the detailed description

The overall goals of this project are to understand how young adults' social media use affects their nicotine vaping and to identify intervention targets that mitigate social media's impact on vaping. Prevalence of vaping and social media use among young adults have increased in tandem. Exposure to vaping-related social media content is common and is associated with vaping. Intense social media use appears to contribute to young adults' increased mental health symptoms, which are linked to tobacco product use. This project aims to contribute to scientific understanding of the causal links between social media use and vaping in young adulthood. Young adults with past-month vaping will report time spent on social media, vaping-related social media content exposure, social comparison on social media, mental health, and vaping behavior. After a 1-month baseline measurement period, they will be randomized to reduce their social media use (incentivized) or use social media as usual for a 3-month experimental period. Longitudinal within- and between-subjects analyses will test relationships between time spent on social media, risk factors for vaping, and vaping behavior. Specific research aims are to: (1) investigate the relationships between a reduction in social media use and: a) vaping content exposure, b) social comparison, and c) mental health, and (2) examine whether reducing social media use reduces past-month vaping days, vaping episodes per vaping day, and puffs per vaping episode.

Being tested
Social Media Use Reduction
Keywords
social media, young adult, e-cigarette, nicotine vaping
Medical subject headings
Vaping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social Media Use ReductionBehavioural

    Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.

Study groups in NCT06142877
Study groupRoleWhat they receive
Social Media Use ReductionExperimentalNot described
Receives: Behavioral: Social Media Use Reduction
Social Media Use as UsualNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Past-month vaping days

    Number of days the participant vaped nicotine in the past 30 days

    Measured: Collected at baseline, 1mo, 3mo, 6mo

Secondary outcomes (2)
  1. Episodes per vaping day

    Average number of times the participant used a nicotine vaping device on each day (of the past 30) they vaped nicotine

    Measured: Collected at baseline, 1mo, 3mo, 6mo

  2. Puffs per vaping episode

    Past-month number of puffs per nicotine vaping episode (1-20)

    Measured: Collected at baseline, 1mo, 3mo, 6mo

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2023
  2. Study start4 Dec 2023
  3. Primary completion1 Feb 2025 (estimated)
  4. Study completion1 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomized to one of two groups: 1) social media use reduction (intervention), or 2) social media use as usual (control).
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06142877
Sponsor's protocol ID
15427
Other IDs
K01DA055073
Status last verified
May 2024
First submitted
15 Nov 2023
Last updated
7 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Deidentified data will be available from the Principal Investigator upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Social Media Use Reduction in people with Electronic Cigarette Use, run by University of Oklahoma at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Erin A Vogel, PhD (405-271-8001 ext. 50493, erin-vogel@ouhsc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Past-month vaping days (time frame: Collected at baseline, 1mo, 3mo, 6mo). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in